Three key prognostic domains warrant investigation: (1) biological markers (baseline cortisol, IL-6, and estrogen profiles); (2) sleep architecture parameters (PSQI sub-scores and actigraphy-measured sleep efficiency); (3) psychological phenotypes (HAMA depression cluster scores and stress resilience scales). Here, IL6 is linked to depressive symptom measurement.